Support and Resistance Basics

What is MACD and how to read it?

How RSI can help?
RSI : 000

Stock Summary

Top Correlated Resources

FAII


Top 10 Correlated Stocks

FAII


In the News

10:01 13 Aug 2022 FAII

ATIP FINAL DEADLINE: HAGENS BERMAN, NATIONAL TRIAL ATTOREYS, Encourages ATI Physical Therapy (ATIP/FAII) Investors with $100k+ Losses to Contact Firm's Attorneys Now, Securities Fraud Class Action Pending

San Francisco, California--(Newsfile Corp. - October 14, 2021) -  Hagens Berman urges ATI Physical Therapy, Inc. (NYSE: ATIP) investors and Fortress Value Acquisition Corp. II (NYSE: FAII) investors with losses in excess of $100,000 to submit your losses now.Class Period: Feb. 22, 2021 - July 23, 2021Lead Plaintiff Deadline: Oct. 15, 2021Visit: www.hbsslaw.com/investor-fraud/ATIP Contact An Attorney Now: ATIP@hbsslaw.com 844-916-0895ATI Physical Therapy, Inc. (ATIP/ FAII) Securities Class Action:...

02:22 13 Aug 2022 FAII

HAGENS BERMAN Encourages ATI Physical Therapy (ATIP/FAII) Investors with $100K+ Losses to Contact Firm's Attorneys, FINAL DEADLINE APPROACHING in Securities Fraud Lawsuit

San Francisco, California--(Newsfile Corp. - September 10, 2021) -  Hagens Berman urges ATI Physical Therapy, Inc. (NYSE: ATIP) investors and Fortress Value Acquisition Corp. II (NYSE: FAII) investors with losses in excess of $100,000 to submit your losses now.Class Period: Apr. 1, 2021 - July 23, 2021Lead Plaintiff Deadline: Oct. 15, 2021Visit: www.hbsslaw.com/investor-fraud/ATIP Contact An Attorney Now: ATIP@hbsslaw.com 844-916-0895ATI Physical Therapy, Inc. (ATIP/ FAII) Securities Class Action:...

01:14 13 Aug 2022 FAII

7 Upcoming SPAC Mergers to Avoid

The stock market has suddenly broken to the downside over the past two weeks. That makes these SPACs particularly risky bets as the momentum fades.

03:32 13 Aug 2022 FAII

U.S. IPO Weekly Recap: Coronavirus Vaccine Developer CureVac Pops 249% In A 4-IPO Week

Four IPOs and six SPACs entered the public markets this past week led by CureVac, which posted the largest first-day pop for a US IPO since 2005.

Financial details

Company Rating
Neutral
Market Cap
443.32M
Income
-
Revenue
-
Book val./share
18.83
Cash/share
2.1
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
-0.98
Forward P/E
-
PEG
-
P/S
3.02
P/B
0.55
P/C
0.54
P/FCF
-9.79
Quick Ratio
1.38
Current Ratio
1.44
Debt / Equity
0.01
LT Debt / Equity
0.01
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
28256.35%
-
-
-
-
SMA20
-29.11%
SMA50
-36%
SMA100
-36%
Inst Own
0%
Inst Trans
0%
ROA
-22%
ROE
-222%
ROC
-0.23%
Gross Margin
-
Oper. Margin
-313%
Profit Margin
-310%
Payout
-
Shs Outstand
34.5M
Shs Float
34.42M
-
-
-
-
Target Price
-
52W Range
9.01-13.05
52W High
-91.31%
52W Low
-87.44%
RSI
35.4
Rel Volume
1.05
Avg Volume
779.71K
Volume
819.41K
Perf Week
1.8%
Perf Month
-34.68%
Perf Quarter
-61.03%
Perf Half Y
-63.43%
-
-
-
-
Beta
-
-
-
Volatility
0.03%, 0.23%
Prev Close
-1.74%
Price
1.13
Change
2.73%

Financial Performance

Quarterly Fundamentals Overview

Last date of statement is 2021-06-30 for Q2

Metric History 2021-06-30
Revenue per share
3.4
Net income per share
-10.49
Operating cash flow per share
-0.63
Free cash flow per share
-1.05
Cash per share
2.1
Book value per share
18.83
Tangible book value per share
-15.91
Share holders equity per share
18.83
Interest debt per share
7.89
Market cap
411.41M
Enterprise value
676.79M
P/E ratio
-0.23
Price to sales ratio
2.8
POCF ratio
-15.18
PFCF ratio
-9.08
P/B Ratio
0.51
PTB ratio
0.51
EV to sales
4.61
Enterprise value over EBITDA
-1.44
EV to operating cash flow
-24.97
EV to free cash flow
-14.94
Earnings yield
-1.1
Free cash flow yield
-0.11
Debt to equity
0.01
Debt to assets
0.61
Net debt to EBITDA
-0.57
Current ratio
1.44
Interest coverage
29.3
Income quality
0.06
Dividend Yield
0
Payout ratio
0
Sales general and administrative to revenue
0
Research and developement to revenue
0
Intangibles to total assets
0.72
Capex to operating cash flow
0.67
Capex to revenue
-0.12
Capex to depreciation
-0.97
Stock based compensation to revenue
0.02
Graham number
66.68
ROIC
-0.23
Return on tangible assets
-0.78
Graham Net
-25.69
Working capital
56.82M
Tangible asset value
-686.13M
Net current asset value
-1.08B
Invested capital
0.44
Average receivables
0
Average payables
0
Average inventory
0
Days sales outstanding
53.74
Days payables outstanding
0
Days of inventory on hand
0
Receivables turnover
1.67
Payables turnover
0
Inventory turnover
0
ROE
-0.56
Capex per share
-0.42

Something similar

Same Sector
Top Correlated Stocks
Similar Market Cap